Amedisys Appoints Permanent CEO

Amedisys, Inc. (NASDAQ:AMED) appointed a permanent CEO yesterday. Effective April 10, Richard Ashworth will take over as CEO, replacing Chairman and interim CEO Paul Kusserow, who had made it clear he was taking over the role temporarily.

Mr. Ashworth most recently served as CEO at Tivity Health, which was acquired by Stone Point Capital in June 2022. Tivity is best known for its Silver Sneakers program that serves Medicare Advantage plans, as Amedisys and the home health industry continue to look toward the growing role of managed care plans in the delivery of healthcare.

Though the market likes Mr. Kusserow in the seat, the role was temporary and this announcement should remove the uncertainty around this position. Paul Kusserow will remain as Chairman.

Symbol Price %chg
MIKA.JK 3070 0
SILO.JK 2540 0
SRAJ.JK 1715 0
HEAL.JK 1335 0
AMED Ratings Summary
AMED Quant Ranking
Related Analysis